Not applicableStudy completedNCT01779141What this trial is testingOrchestra Pregnancy Observational Study in PolandWho this might be right forType 1 Diabetes MellitusPregnancy Medtronic MiniMed, Inc. 481
Early research (Phase 1)Study completedNCT00851773What this trial is testingSafety, Tolerability, and Profile of Action of Drug in the Body of NN9535 in Healthy Male Japanese and Caucasian SubjectsWho this might be right forDiabetesHealthy Novo Nordisk A/S 84
Testing effectiveness (Phase 2)Active Not RecruitingNCT05139602What this trial is testingAssess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic TherapyWho this might be right forHidradenitis Suppurativa AbbVie 210
Early research (Phase 1)Study completedNCT02165345What this trial is testingExtension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic ArthritisWho this might be right forJuvenile Idiopathic Arthritis Hoffmann-La Roche 82
Early research (Phase 1)Study completedNCT04136145What this trial is testingSingle Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy SubjectsWho this might be right forSystemic Lupus Erythematosus GlaxoSmithKline 36
Not applicableStudy completedNCT01310569What this trial is testingSubcutaneous Adipose Tissue in Cases With Polycystic Ovarian SyndromeWho this might be right forPolycystic Ovary Syndrome Gulhane School of Medicine 52
Testing effectiveness (Phase 2)Ended earlyNCT02515669What this trial is testingStudy of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMDWho this might be right forMuscular Dystrophy (DMD) Hoffmann-La Roche 43
Large-scale testing (Phase 3)Ended earlyNCT02937766What this trial is testingStudy Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) When Administered Via Subcutaneous Auto-injector vs Intramuscular Injection Via Needle and Syringe in Healthy Post-menopausal WomenWho this might be right forAssessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) in Healthy Post-menopausal Women AMAG Pharmaceuticals, Inc. 60
Early research (Phase 1)WithdrawnNCT06411639What this trial is testingPharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune DiseasesWho this might be right forSjogren DiseaseSystemic Lupus Erythematosus Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Active Not RecruitingNCT04933539What this trial is testingSubcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple MyelomaWho this might be right forMultiple Myeloma National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Study completedNCT03788291What this trial is testingAcalabrutinib and High Frequency Low Dose Subcutaneous Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia / Small Lymphocytic LymphomaWho this might be right forChronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL) University of Rochester 39
Early research (Phase 1)Study completedNCT01507610What this trial is testingBioavailability Study to Compare OPTINOSE SUMATRIPTAN With IMITREX® in Healthy SubjectsWho this might be right forMigraine Optinose US Inc. 20
Early research (Phase 1)Not Yet RecruitingNCT07283640What this trial is testingA Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic LeukemiaWho this might be right forBlinatumomabRevumenibLymphoblastic Leukemia+1 more M.D. Anderson Cancer Center 20
Not applicableLooking for participantsNCT05428345What this trial is testingVedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South KoreaWho this might be right forUlcerative ColitisCrohn's DiseaseInflammatory Bowel Disease (IBD) Takeda 600
Not applicableStudy completedNCT06076434What this trial is testingLow-Molecular-Weight Heparin Injection in Stroke PatientsWho this might be right forStroke Kastamonu University 50
Large-scale testing (Phase 3)Ended earlyNCT00680563What this trial is testingOnce-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.Who this might be right forAnemia Hoffmann-La Roche 4
Early research (Phase 1)Study completedNCT05017012What this trial is testingEvaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC) Injection of Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180) [MK-3475A] In Advanced Solid Tumors (MK-3475A-C18)Who this might be right forAdvanced or Metastatic Solid Tumors Merck Sharp & Dohme LLC 142
Early research (Phase 1)Study completedNCT05395481What this trial is testingA Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Who this might be right forMetabolic Dysfunction-Associated Steatohepatitis (MASH)Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) Eli Lilly and Company 115
Early research (Phase 1)Study completedNCT05152277What this trial is testingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS9531 in Healthy SubjectsWho this might be right forType 2 Diabetes Fujian Shengdi Pharmaceutical Co., Ltd. 90
Early research (Phase 1)Ended earlyNCT04117607What this trial is testingSafety and Pharmacokinetics of RezafunginWho this might be right forFungal Infection National Institute of Allergy and Infectious Diseases (NIAID) 14